Search Results for 'Sofosbuvir Ctp'

Sofosbuvir Ctp published presentations and documents on DocSlides.

Sofosbuvir
Sofosbuvir
by conchita-marotz
ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
Ledipasvir-Sofosbuvir in GT-1
Ledipasvir-Sofosbuvir in GT-1
by faustina-dinatale
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
Sofosbuvir in
Sofosbuvir in
by giovanna-bartolotta
Genotype . 2. . or 3 . FUSION. Trial. Phase . ...
Ledipasvir-Sofosbuvir in GT1 or GT4 and HIV Coinfection
Ledipasvir-Sofosbuvir in GT1 or GT4 and HIV Coinfection
by pasty-toler
ION-4. Phase . 3. Treatment. Naïve and Treatmen...
Sofosbuvir + Ribavirin in HCV Genotype 1
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Sofosbuvir in HCV-
Sofosbuvir in HCV-
by mitsue-stanley
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
by pamella-moone
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
Ledipasvir-Sofosbuvir (
Ledipasvir-Sofosbuvir (
by lindy-dunigan
Harvoni. ). Prepared by: . David H. Spach, MD and...
Ledipasvir-Sofosbuvir +/- 3
Ledipasvir-Sofosbuvir +/- 3
by alexa-scheidler
rd. DAA in HCV Genotype 1 . NIAID SYNERGY: Genot...
Sofosbuvir in Genotypes 2 or 3
Sofosbuvir in Genotypes 2 or 3
by giovanna-bartolotta
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
by debby-jeon
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by trish-goza
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
Sofosbuvir-Velpatasvir  in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Sofosbuvir-Velpatasvir  in HCV Genotype 1, 2, 4, 5, or 6
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Ledipasvir-Sofosbuvir ( Harvoni
Ledipasvir-Sofosbuvir ( Harvoni
by sherrill-nordquist
). Slide deck prepared . by: . David H. Spach, MD...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
Sofosbuvir  + Ribavirin to Prevent Post-Transplant HCV Recurrence
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
Daclatasvir  + Sofosbuvir + RBV in GT3
Daclatasvir + Sofosbuvir + RBV in GT3
by sophia2
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
Sofosbuvir  + Ribavirin in HCV Recurrence
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
Daclatasvir
Daclatasvir
by giovanna-bartolotta
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Daclatasvir
Daclatasvir
by tatyana-admore
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...
Sofosbuvir
Sofosbuvir
by luanne-stotts
+ Ribavirin to Prevent Post-Transplant HCV Recur...
Trent W Nichols
Trent W Nichols
by cheryl-pisano
Hepatitis-2015. Orlando. , USA. July 20 - 22 20...
Daclatasvir
Daclatasvir
by trish-goza
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Simeprevir
Simeprevir
by olivia-moreira
. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...
Newest Drugs for Hepatitis C
Newest Drugs for Hepatitis C
by tawny-fly
Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...
Elbasvir-Grazoprevir
Elbasvir-Grazoprevir
by celsa-spraggs
. + . Sofosbuvir. . in Treatment-Naïve HCV Gen...
Sofosbuvir, Ribavirin, GS
Sofosbuvir, Ribavirin, GS
by min-jolicoeur
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
Sofosbuvir-Velpatasvir-Voxilaprevir
Sofosbuvir-Velpatasvir-Voxilaprevir
by faustina-dinatale
in DAA. -Naïve GT . 1-6 . POLARIS-2. Phase 3. ...
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Overcoming Patent barriers to hepatitis C treatment
Overcoming Patent barriers to hepatitis C treatment
by karlyn-bohler
. The Hepatitis C Treatment Revolution . Expandi...
Access and affordability – Hepatitis C
Access and affordability – Hepatitis C
by olivia-moreira
Suzanne Hill . IPC. , December 2015. acknowledge...
2014: HIV, HCV, and  HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Andrew I. Aronsohn, MD Associate Professor of Medicine
Andrew I. Aronsohn, MD Associate Professor of Medicine
by alida-meadow
University of Chicago. Chicago, Illinois. Challen...
Access and affordability – Hepatitis C
Access and affordability – Hepatitis C
by olivia-moreira
Suzanne Hill . IPC. , December 2015. acknowledge...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Ledipasvir Sofosbuvir in GT and HIV Coinfection NIAID
Ledipasvir Sofosbuvir in GT and HIV Coinfection NIAID
by myesha-ticknor
JAMA 20153131232 9 HIV Coinfection brPage 2br Sou...
Advances in Hepatitis C Identification and Treatment
Advances in Hepatitis C Identification and Treatment
by giovanna-bartolotta
Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...